Kinsap Medisciences Private Limited, a active private limited company, was established on 02 January 2006 in 69, Green Park, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230GJ2006PTC047424. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.48 M.
It upholds a compliant status. Its leadership includes Kishori Lal Jaiswal (Whole-Time Director), Urmila Anish Buchasia (Whole-Time Director), Saket Kishorilal Jaiswal (Managing Director). Past directors included Saket Kishorilal Jaiswal, Manoharlal Ramnarain Jaiswal, Manohar Ramnarayanprasad Jaiswal. It holds no open charges and ₹4.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 69, Green Parkambali Bopal,Ahmedabad, 69, Green Park, Gujarat.
U24230GJ2006PTC047424
047424
02 January 2006
₹0.50 M
₹0.48 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Kinsap Medisciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kishori Lal Jaiswal | Whole-Time Director | 31 Mar 2015 | Current |
| Urmila Anish Buchasia | Whole-Time Director | 31 Mar 2015 | Current |
| Saket Kishorilal Jaiswal | Managing Director | 02 Jan 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Dec 2012 | Past |
| Pramod Abcsdd | Whole Time Director | - | Past |
| Pramod Abcsdd | Whole-Time Director | 17 Jan 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kinsap Medisciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14819.32% increase. The company also saw a substantial improvement in profitability, with a 12742.55% increase in profit. The company's net worth Soared by an impressive increase of 32.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Kinsap Medisciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹4,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2006 | Dena Bank | ₹4.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kinsap Medisciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kinsap Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kinsap Medisciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kinsap Medisciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Kinsap Medisciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
A charge registered on 18 Oct 2006 via Charge ID 10026772 with Dena Bank was fully satisfied on 07 Jan 2022. was recorded as a recent event.
The activity Kishori Lal Jaiswal was appointed as a Whole-time director was appointed as a Whole-time director on 31 Mar 2015 & has been associated with this company since 10 years 8 months . was completed.
Urmila Anish Buchasia was appointed as a Whole-time director was appointed as a Whole-time director on 31 Mar 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
The activity A charge with Dena Bank of Rs. 4.00 M registered on 18 Oct 2006 with Charge ID 10026772 was modified on 01 Mar 2012. was completed.
The CIN of Kinsap Medisciences Private Limited is U24230GJ2006PTC047424.
Kinsap Medisciences Private Limited is headquartered at 69, Green Parkambali Bopal,Ahmedabad, 69, Green Park, Gujarat.
Kinsap Medisciences Private Limited was incorporated on 02 January 2006.
The current directors of Kinsap Medisciences Private Limited are
The primary industry of Kinsap Medisciences Private Limited is Trade.
Kinsap Medisciences Private Limited is unlisted.
The authorized capital of Kinsap Medisciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.48 M.
The compliance status of Kinsap Medisciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX